Harvard Researcher Advocates DMAA Ban

May 9, 2012 -- Despite growing evidence regarding the dangers of DMAA, it technically remains legal in the United States. Dr. Pieter Cohen, a researcher at Harvard, has recently published an editorial in the Archives of Internal Medicine advocating for...

Possible Financial Ties Between Drugmakers, Pain Advocacy Foundations

May 9, 2012 -- Since the 1990s, prescriptions of opioid painkillers for chronic conditions have skyrocketed, and so have the number of severe additions and overdose deaths. In 2011, several independent journalist investigations unearthed startling evidence that several nonprofit pain...

Health Canada Warns of Metal-on-Metal Hip Implant Risks

May 8, 2012 -- Health Canada, a federal agency that advocates for the health of Canadians, has issued a new warning about the risks associated with metal-on-metal hip implants. An estimated 10% of Canadians with hip implants have the metal-on-metal...

Pradaxa

Texas Pradaxa Gastrointestinal Bleeding Lawyer

Pradaxa is a new blood-thinning medication invented by the drug company Boehringer Ingelheim. Since it was approved in 2010, Pradaxa has been linked to hundreds of deaths, many caused by gastrointestinal bleeding.

Pradaxa

Elderly Females at Risk of Severe Pradaxa Side Effects

A new study has analyzed the risk of severe side effects among patients who switched from Coumadin to Pradaxa. Dr. Mark Wurster presented the research at the Thrombosis & Hemostasis Summit of North America 2012.

Study Finds Clomid Triples Risk of Birth Defects

May 8, 2012 -- A new study published in the May 5 issue of the New England Journal of Medicine has found that babies are more likely to have birth defects when they are born to couples who use fertility...

First Federal Transvaginal Mesh Trial Set for February 2013

The first bellwether trial against C.R. Bard, the company responsible for thousands of transvaginal mesh injuries, has been set for February 5, 2013.

Medtronic May Have Downplayed Risks of Infuse Bone Graft

May 8, 2012 -- Medtronic, the company responsible for the Medtronic Infuse Bone Graft, is currently under Congressional investigation following journalist reports that the company paid doctors to falsify reports and inflate safety data to promote their product. The company...

Study Finds Metal-on-Metal Hip Implants Corrode More Quickly, Severely

May 8, 2012 -- A new study adds more evidence that metal-on-metal hip implants corrode more quickly and severely than metal-on-plastic hip implants. The parts of a metal-on-metal hip replacement grind together, and over time, they can shed chromium and...

DMAA Health Risks Prompt Search for Next Stimulant Drug

May 7, 2012 -- Since the U.S. Food and Drug Administration (FDA) restricted sales of DMAA last week, the search is on for the next stimulant drug. Ten different companies were sent warning letters from the FDA, and some of...